We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMO
3051
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$224K ﹤0.01%
3,428
+142
+4% +$10.1K
EEA
3052
European Equity Fund
EEA
$76.6M
$223K ﹤0.01%
23,017
-10,604
-32% -$106K
NWN icon
3053
Northwest Natural Holdings
NWN
$2.09B
$223K ﹤0.01%
3,873
-535
-12% -$30K
PZN
3054
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$223K ﹤0.01%
20,000
CGW icon
3055
Invesco S&P Global Water Index ETF
CGW
$1.07B
$222K ﹤0.01%
6,523
-498
-7% -$17.2K
AFB
3056
AllianceBernstein National Municipal Income Fund
AFB
$316M
$221K ﹤0.01%
17,638
+4,217
+31% +$54.2K
LITE icon
3057
CALL
Lumentum
LITE
$63.3B
$221K ﹤0.01%
+33,000
New +$1.89M
NVRI icon
3058
Enviri
NVRI
$615M
$221K ﹤0.01%
+10,710
New +$206K
ALG icon
3059
Alamo Group
ALG
$2.06B
$220K ﹤0.01%
2,002
+6
+0.3% +$679
HPR
3060
DELISTED
HighPoint Resources Corporation
HPR
$220K ﹤0.01%
+865
New +$220K
TCON
3061
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$219K ﹤0.01%
475
-6
-1% -$3.27K
PTE
3062
DELISTED
PolarityTE, Inc. Common Stock
PTE
$219K ﹤0.01%
+483
New +$244K
GTO icon
3063
Invesco Total Return Bond ETF
GTO
$2.47B
$218K ﹤0.01%
+4,159
New +$218K
KTF
3064
DWS Municipal Income Trust
KTF
$352M
$218K ﹤0.01%
19,451
-4,133
-18% -$47.2K
KDNY
3065
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$218K ﹤0.01%
4,690
-9
-0.2% -$329
PXLC
3066
DELISTED
POWERSHARES FUNDAMENTAL PURE LARGE CORE PORTFOLIO
PXLC
$218K ﹤0.01%
4,200
-1,024
-20% -$53.1K
ZEN
3067
DELISTED
ZENDESK INC
ZEN
$217K ﹤0.01%
+4,540
New +$188K
NNY icon
3068
Nuveen New York Municipal Value Fund
NNY
$156M
$216K ﹤0.01%
23,540
-3,789
-14% -$35.4K
RMCF icon
3069
Rocky Mountain Chocolate Factory
RMCF
$7.37M
$216K ﹤0.01%
17,950
-1,211
-6% -$14.8K
AGI icon
3070
Alamos Gold
AGI
$13.9B
$215K ﹤0.01%
+41,246
New +$231K
ALGT icon
3071
Allegiant Air
ALGT
$2.41B
$215K ﹤0.01%
1,244
-454
-27% -$75.1K
EC icon
3072
Ecopetrol
EC
$35.1B
$215K ﹤0.01%
+11,100
New +$198K
NEN icon
3073
New England Realty Associates
NEN
$197M
$215K ﹤0.01%
3,060
CENT icon
3074
Central Garden & Pet Co
CENT
$2.75B
$214K ﹤0.01%
+6,231
New +$197K
CFFN icon
3075
Capitol Federal Financial
CFFN
$1.08B
$214K ﹤0.01%
+17,355
New +$225K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.